51
Participants
Start Date
August 31, 2006
Primary Completion Date
July 31, 2009
Study Completion Date
October 31, 2012
Docetaxel
"Sequential Therapy: Docetaxel will be given at 100 mg/m\^2 Intravenously (IV)Day 1 every 3 weeks for 4 cycles.~Concurrent Therapy: Docetaxel will be given at 50 mg/m\^2 IV Day 1."
Capecitabine
Sequential Therapy: administration of capecitabine 1000 mg/m\^2 twice a day by mouth Day 1-14 every 3 weeks for 4 cycles (total 8 cycles) Concurrent Therapy: capecitabine 1000 mg/m\^2 twice a day by mouth Day 1-7 every 2 weeks for 8 cycles (total 16 weeks).
Suburban Hematology-Oncology Associates, PC, Lawrenceville
WellStar Health System-Georgia Cancer Specialists, Marietta
WellStar Health System-Northwest Georgia Oncology Center, PC, Marietta
Suburban Hematology-Oncology Associates, PC, Snellville
Suburban Hematology-Oncology Associates, PC, Duluth
WellStar Health System-Georgia Cancer Specialists, Austell
WellStar Health System-Northwest Georgia Oncology Center, PC, Austell
WellStar Health System-Northwest Georgia Oncology Center, PC, Carrollton
South Atlanta Hematology-Oncology Group, Riverdale
South Atlanta Hematology-Oncology Group, Stockbridge
Grady Memorial Hospital, Atlanta
Emory Crawford Long Hospital, Atlanta
Emory University Winship Cancer Institute, Atlanta
South Atlanta Hematology-Oncology Group, East Point
Augusta Oncology Associates, PC 1348 Walton Way, Ste. 4300, Augusta
Augusta Oncology Associates, PC 3696 Wheeler Road, Augusta
Central Georgia Cancer Care, PC, Warner Robins
Central Georgia Cancer Care, PC, Macon
John B. Amos Cancer Center, Columbus
Collaborators (1)
Georgia Center for Oncology Research & Education
OTHER
Sanofi
INDUSTRY
Emory University
OTHER